Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Stocks tipped to nudge up at the outset

Consolidation looks to be the name of the game, with the blue-chip benchmarks set to open a tad firmer

Stocks are set to open little changed heading into the weekend, with a slight bias to the upside.

Spread betting quotes indicate the Dow Jones industrial average, which yesterday added 217 points, or almost 1.3%, to creep above the 17,000 level once again to 17,142, will open at around 17,150.

The broader-based S&P 500, which closed up 1.5% at 2,024, is seen a little more than a point higher.

Hotels and casinos operator Wynn Resorts (NYSE:WYNN) is expected to see a sell-off when trading starts after its Macau operations posted an alarming decline of almost 40% yesterday.

Toys maker Mattel (NASDAQ@MAT) missed its earnings estimates in results published after the bell last night, but investors seem do not seem to be in a mood to throw their toys out of the pram, with the shares up 3.1% in pre-market trading.

Chip maker Advanced Micro Devices (NASDAQ:AMD) is also advancing in pre-market trading, despite its third quarter loss per share of 17 cents being five cents a share higher than analysts had forecast.

Ahead of the bell this morning, General Electric (NYSE:GE) was little changed in screen-based trading after a solid performance in what chief executive and chairman Jeff Immelt said was “a volatile environment” in the third quarter.

Underlying earnings per share, at 29 cents, were better than the figure of 25 cents analysts had penciled in for the industrial giant.

Third quarter results from technology firm Honeywell (NYSE:HON) were a mixed bag, with earnings ahead of Wall Street’s expectations and sales below them.

The maker of aviation components and control systems’ earnings per share of US$1.60 topped the consensus forecast of US$1.55, but revenue of US$9.61bn was down 5% year-on-year and less than the US$9.85bn analysts had predicted.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK